Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novartis AG ADR buy Citigroup Inc.

Start price
€131.00
05.02.26 / 50%
Target price
-
05.02.27
Performance (%)
3.82%
Price
€136.00
12.02.26
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ shows slight gains of 3.82%. This prediction currently runs until 05.02.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Novartis AG ADR 3.817%
iShares Core DAX® 1,93 %
iShares Nasdaq 100 -0,18 %
iShares Nikkei 225® 7,08 %
iShares S&P 500 -0,20 %

Comments by Citigroup_Inc_ for this prediction

In the thread Novartis AG ADR diskutieren

Novartis (NYSE:NVS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for NVS provided by MarketBeat